Arsenal Capital Management

InterShunt designs and develops a catheter-based minimally-invasive procedure to provide relief for millions suffering from heart failure. It believes that left atrial decompression holds the key to reducing symptoms for those who suffer. It also believes that they can do this using a simple catheter procedure. Most importantly, they believe they can do this without the use of an implant. It was founded in 2015 and is headquartered in St Louis, Missouri.

Juristat is a provider of a patent analytics platform that leverages public patent data to enhance patent prosecution strategies for law firms and in-house counsel. The platform utilizes a proprietary natural language processing algorithm to analyze the past behaviors of patent examiners at the United States Patent and Trademark Office (USPTO). By generating Examiner Reports, Juristat enables users to predict future examiner behavior, thereby increasing allowance rates and reducing time and costs associated with patent applications. The platform allows for detailed filtering of data based on individual examiners, art units, assignees, application types, and claims, while also tracking behavioral changes over time. Juristat's extensive database includes complete image file wrappers for over 5.5 million patent applications and covers 99% of all active art units and examiners, providing comprehensive insights for optimizing responses to office actions.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Deck Commerce is a cloud-based solution platform that focuses on enhancing e-commerce operations for retailers. It addresses challenges related to data integration and business processes in the retail environment. The platform offers features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small e-commerce businesses to efficiently manage orders, inventory, and product data, thereby optimizing their operational processes.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

Aptimmune is a biotechnology company based in St. Louis, Missouri, founded in 2010. The company specializes in developing mucosal vaccines for swine to combat viral diseases, specifically targeting Porcine Reproductive and Respiratory Syndrome virus (PRRSV) and influenza A virus. Aptimmune employs innovative technologies, including its proprietary pig alveolar macrophage cell line ZMAC, to create effective nasal delivery vaccines. These advancements aim to provide animal breeders with lasting immune responses and enhanced disease protection, contributing to the overall health and productivity of swine populations.

Deck Commerce is a cloud-based solution platform that focuses on enhancing e-commerce operations for retailers. It addresses challenges related to data integration and business processes in the retail environment. The platform offers features such as enterprise inventory visibility, universal product information, and distributed order management. By connecting front-end shopping channels with back-end business systems, Deck Commerce enables small e-commerce businesses to efficiently manage orders, inventory, and product data, thereby optimizing their operational processes.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on transforming workplace culture by providing technology that enhances employee recognition, communication, feedback, and event management. Its mobile-first platform offers real-time communication tools such as announcements, targeted broadcasts, and pop surveys, which help organizations foster camaraderie, align their culture, and gather valuable HR insights. By modernizing employee communications, Bonfyre enables companies to build stronger relationships and increase engagement, ultimately promoting a collaborative and innovative work environment.

Bonfyre Inc. is an employee engagement platform founded in 2013 and based in Saint Louis, Missouri. The company focuses on transforming workplace culture by providing technology that enhances employee recognition, communication, feedback, and event management. Its mobile-first platform offers real-time communication tools such as announcements, targeted broadcasts, and pop surveys, which help organizations foster camaraderie, align their culture, and gather valuable HR insights. By modernizing employee communications, Bonfyre enables companies to build stronger relationships and increase engagement, ultimately promoting a collaborative and innovative work environment.

Harbor MedTech, Inc. is a regenerative medicine company based in Irvine, California, specializing in the development and commercialization of tissue regeneration products. Founded in 2010, the company offers a range of solutions for chronic wounds, hernia and joint repair, and soft tissue reinforcement. Notable products include Architect, an extracellular collagen matrix designed for managing various skin wounds, and EPMatrix, a collagen scaffold aimed at soft tissue repair. The company's innovative BriDGE platform enables the creation of advanced therapies for applications including breast reconstruction, Achilles tendon repair, and rotator cuff repair, as well as other surgical needs in dermatology and general surgery. Harbor MedTech is also engaged in a strategic partnership with Edwards Lifesciences to enhance its product offerings and market reach.

Synek created the SYNEK beer dispenser and personally thanked every backer by taking a 42-city RV tour to deliver the 2,500 pre-ordered dispensers. The SYNEK beer dispenser refrigerates, pressurizes, and dispenses beer in the coolest way possible—brewery-quality beer, fresh on draft, in your home.

KEW Group is a personalized oncology management company based in Cambridge, Massachusetts, founded in 2009. It specializes in DNA-based genomic testing and interpretation services, aiming to enhance cancer care through individualized treatment options. By leveraging proprietary oncology therapeutic pathways and personalized medicine tools, KEW Group utilizes genetic and genomic information to inform clinical decision-making in community oncology settings. The company's focus is on identifying genetic variants in solid tumors and matching them with targeted therapies, thereby improving treatment decisions and the overall quality of patient care. KEW Group is committed to advancing oncology precision medicine and expanding the capabilities of molecular labs in the field.

Kypha Inc. is a life sciences company focused on developing and commercializing in-vitro diagnostic biomarker tests for inflammation and autoimmune disorders. Based in St. Louis, Missouri, the company offers the COMP ACT System, which enhances the monitoring and treatment of various health conditions, including lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. Kypha aims to provide rapid and accurate assessments of inflammation levels, enabling healthcare professionals to make timely and informed clinical decisions. With a core team supported by scientific advisors and clinical collaborators, Kypha has successfully secured federal grants and raised private capital to advance its diagnostic products toward regulatory approval and market launch. The company's technology is designed for scalability, facilitating testing in diverse settings from home health to clinical laboratories, ultimately improving patient outcomes through timely intervention.

TransMed Systems develops and deploys software solutions that facilitate exploration, reporting, and analysis of clinical, molecular, and healthcare operational data. TransMed's BIS provides an integrated bio-informatics platform enabling clinical and research organizations to aggregate data from multiple sources, easily explore data, and perform research and/or practice specific analysis. TransMed's platform unlocks the potential of the healthcare repository by tightly integrating analytics with aggregated data providing self-service analysis of all bio-clinical data sources in a framework usable by clinicians and investigators. Our solutions are used by health sciences researchers as well as clinicians interested in the application of information technology to the challenges of basic research and turning research into improved clinical practices. Our Bioinformatics solution is composed of four core capabilities leveraging our meta-data driven repository that aggregates data from disparate health data sources.